HEADER PROTEIN FIBRIL 19-JUL-17 5WIQ TITLE CRYSTAL STRUCTURE OF THE SEGMENT, GFNGGFG, FROM THE LOW COMPLEXITY TITLE 2 DOMAIN OF TDP-43, RESIDUES 396-402 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TAR DNA-BINDING PROTEIN 43; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 396-402; COMPND 5 SYNONYM: TDP-43; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 OTHER_DETAILS: SYNTHETIC PEPTIDE GFNGGFG CORRESPONDING TOSEGMENT SOURCE 7 396-402 OF TDP-43 KEYWDS AMYLOID, LARKS, TDP-43, PROTEIN FIBRIL EXPDTA X-RAY DIFFRACTION AUTHOR E.L.GUENTHER,M.R.SAWAYA,D.S.EISENBERG REVDAT 7 04-OCT-23 5WIQ 1 REMARK REVDAT 6 18-DEC-19 5WIQ 1 REMARK REVDAT 5 20-FEB-19 5WIQ 1 REMARK REVDAT 4 20-JUN-18 5WIQ 1 JRNL REVDAT 3 06-JUN-18 5WIQ 1 JRNL REVDAT 2 30-MAY-18 5WIQ 1 JRNL REVDAT 1 18-APR-18 5WIQ 0 JRNL AUTH E.L.GUENTHER,Q.CAO,H.TRINH,J.LU,M.R.SAWAYA,D.CASCIO, JRNL AUTH 2 D.R.BOYER,J.A.RODRIGUEZ,M.P.HUGHES,D.S.EISENBERG JRNL TITL ATOMIC STRUCTURES OF TDP-43 LCD SEGMENTS AND INSIGHTS INTO JRNL TITL 2 REVERSIBLE OR PATHOGENIC AGGREGATION. JRNL REF NAT. STRUCT. MOL. BIOL. V. 25 463 2018 JRNL REFN ESSN 1545-9985 JRNL PMID 29786080 JRNL DOI 10.1038/S41594-018-0064-2 REMARK 2 REMARK 2 RESOLUTION. 1.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.53 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.050 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.9 REMARK 3 NUMBER OF REFLECTIONS : 1796 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.153 REMARK 3 R VALUE (WORKING SET) : 0.152 REMARK 3 FREE R VALUE : 0.168 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.020 REMARK 3 FREE R VALUE TEST SET COUNT : 180 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 22.5336 - 1.2424 0.93 1616 180 0.1516 0.1678 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.000 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 14.980 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 2.51 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 3.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 96 REMARK 3 ANGLE : 0.692 124 REMARK 3 CHIRALITY : 0.128 6 REMARK 3 PLANARITY : 0.002 20 REMARK 3 DIHEDRAL : 7.493 26 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -0.2349 -1.8711 -12.5061 REMARK 3 T TENSOR REMARK 3 T11: 0.0163 T22: 0.0126 REMARK 3 T33: 0.0175 T12: 0.0038 REMARK 3 T13: -0.0040 T23: 0.0042 REMARK 3 L TENSOR REMARK 3 L11: 0.5457 L22: 0.8184 REMARK 3 L33: 0.7135 L12: 0.0629 REMARK 3 L13: 0.1837 L23: 0.3668 REMARK 3 S TENSOR REMARK 3 S11: 0.0173 S12: 0.0030 S13: -0.0104 REMARK 3 S21: 0.0076 S22: 0.0093 S23: -0.0112 REMARK 3 S31: 0.0267 S32: 0.0065 S33: -0.0127 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5WIQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JUL-17. REMARK 100 THE DEPOSITION ID IS D_1000229099. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUN-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 1802 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.250 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.4 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.16100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.4 REMARK 200 DATA REDUNDANCY IN SHELL : 1.80 REMARK 200 R MERGE FOR SHELL (I) : 0.40600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5WDB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 9.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM SODIUM ACETATE PH 4.5, 800MM REMARK 280 SODIUM PHOSPHATE MONOBASIC, 1200MM POTASSIUM PHOSPHATE DIBASIC, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DECAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -9.62000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 1.000000 0.000000 0.000000 -4.81000 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 4.81000 REMARK 350 BIOMT2 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 5 1.000000 0.000000 0.000000 9.62000 REMARK 350 BIOMT2 5 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 5 0.000000 0.000000 1.000000 0.00000 DBREF 5WIQ A 396 402 UNP Q13148 TADBP_HUMAN 396 402 DBREF 5WIQ B 396 402 UNP Q13148 TADBP_HUMAN 396 402 SEQRES 1 A 7 GLY PHE ASN GLY GLY PHE GLY SEQRES 1 B 7 GLY PHE ASN GLY GLY PHE GLY FORMUL 3 HOH *8(H2 O) CRYST1 4.810 16.439 22.672 90.63 96.37 91.26 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.207900 0.004584 0.023281 0.00000 SCALE2 0.000000 0.060846 0.000824 0.00000 SCALE3 0.000000 0.000000 0.044386 0.00000 ATOM 1 N GLY A 396 0.660 0.002 -1.652 1.00 3.97 N ANISOU 1 N GLY A 396 629 503 378 21 -69 25 N ATOM 2 CA GLY A 396 -0.167 0.770 -2.567 1.00 3.76 C ANISOU 2 CA GLY A 396 569 481 378 17 -40 18 C ATOM 3 C GLY A 396 0.487 0.934 -3.929 1.00 2.89 C ANISOU 3 C GLY A 396 432 361 307 28 -49 17 C ATOM 4 O GLY A 396 1.708 0.849 -4.051 1.00 4.83 O ANISOU 4 O GLY A 396 673 601 563 38 -73 11 O ATOM 5 N PHE A 397 -0.332 1.157 -4.955 1.00 3.89 N ANISOU 5 N PHE A 397 539 487 452 25 -31 20 N ATOM 6 CA PHE A 397 0.125 1.346 -6.326 1.00 4.40 C ANISOU 6 CA PHE A 397 584 543 543 31 -34 21 C ATOM 7 C PHE A 397 -0.433 2.667 -6.829 1.00 4.74 C ANISOU 7 C PHE A 397 614 585 603 33 -21 13 C ATOM 8 O PHE A 397 -1.630 2.936 -6.671 1.00 3.85 O ANISOU 8 O PHE A 397 497 478 489 32 -8 10 O ATOM 9 CB PHE A 397 -0.389 0.199 -7.220 1.00 2.61 C ANISOU 9 CB PHE A 397 359 314 321 28 -33 35 C ATOM 10 CG PHE A 397 -0.019 0.329 -8.689 1.00 1.91 C ANISOU 10 CG PHE A 397 255 220 250 33 -34 35 C ATOM 11 CD1 PHE A 397 1.007 -0.433 -9.232 1.00 2.26 C ANISOU 11 CD1 PHE A 397 298 261 300 38 -46 33 C ATOM 12 CD2 PHE A 397 -0.716 1.188 -9.529 1.00 2.88 C ANISOU 12 CD2 PHE A 397 369 343 383 33 -23 36 C ATOM 13 CE1 PHE A 397 1.341 -0.323 -10.576 1.00 3.51 C ANISOU 13 CE1 PHE A 397 445 419 468 40 -40 31 C ATOM 14 CE2 PHE A 397 -0.384 1.302 -10.871 1.00 1.41 C ANISOU 14 CE2 PHE A 397 178 152 203 34 -23 39 C ATOM 15 CZ PHE A 397 0.644 0.545 -11.394 1.00 2.09 C ANISOU 15 CZ PHE A 397 263 240 290 35 -28 36 C ATOM 16 N ASN A 398 0.426 3.476 -7.450 1.00 1.47 N ANISOU 16 N ASN A 398 192 162 205 34 -25 7 N ATOM 17 CA ASN A 398 0.008 4.701 -8.123 1.00 1.49 C ANISOU 17 CA ASN A 398 191 153 223 35 -18 5 C ATOM 18 C ASN A 398 0.693 4.746 -9.476 1.00 2.21 C ANISOU 18 C ASN A 398 280 236 324 29 -17 15 C ATOM 19 O ASN A 398 1.919 4.611 -9.551 1.00 1.48 O ANISOU 19 O ASN A 398 181 145 236 22 -19 10 O ATOM 20 CB ASN A 398 0.414 5.951 -7.329 1.00 1.65 C ANISOU 20 CB ASN A 398 213 164 250 35 -20 -13 C ATOM 21 CG ASN A 398 -0.202 5.982 -5.954 1.00 5.08 C ANISOU 21 CG ASN A 398 652 609 668 40 -18 -27 C ATOM 22 OD1 ASN A 398 -1.366 6.332 -5.796 1.00 4.56 O ANISOU 22 OD1 ASN A 398 584 547 603 48 -8 -34 O ATOM 23 ND2 ASN A 398 0.574 5.602 -4.949 1.00 3.09 N ANISOU 23 ND2 ASN A 398 407 366 399 37 -28 -35 N ATOM 24 N GLY A 399 -0.085 4.964 -10.532 1.00 1.43 N ANISOU 24 N GLY A 399 186 130 228 33 -15 27 N ATOM 25 CA GLY A 399 0.488 5.079 -11.860 1.00 1.46 C ANISOU 25 CA GLY A 399 196 128 232 24 -11 37 C ATOM 26 C GLY A 399 -0.293 4.302 -12.896 1.00 1.76 C ANISOU 26 C GLY A 399 237 171 260 30 -14 49 C ATOM 27 O GLY A 399 -1.521 4.186 -12.794 1.00 2.34 O ANISOU 27 O GLY A 399 309 246 335 42 -22 50 O ATOM 28 N GLY A 400 0.384 3.774 -13.905 1.00 2.53 N ANISOU 28 N GLY A 400 339 274 349 23 -8 53 N ATOM 29 CA GLY A 400 -0.373 3.011 -14.876 1.00 2.93 C ANISOU 29 CA GLY A 400 395 330 389 29 -15 60 C ATOM 30 C GLY A 400 0.403 2.793 -16.164 1.00 2.66 C ANISOU 30 C GLY A 400 371 300 339 19 -4 63 C ATOM 31 O GLY A 400 1.634 2.755 -16.164 1.00 2.55 O ANISOU 31 O GLY A 400 349 293 328 8 11 54 O ATOM 32 N PHE A 401 -0.361 2.649 -17.246 1.00 1.85 N ANISOU 32 N PHE A 401 286 197 221 24 -14 72 N ATOM 33 CA PHE A 401 0.121 2.045 -18.485 1.00 1.76 C ANISOU 33 CA PHE A 401 285 195 187 18 -5 70 C ATOM 34 C PHE A 401 -0.370 2.886 -19.653 1.00 3.53 C ANISOU 34 C PHE A 401 544 409 387 15 -12 89 C ATOM 35 O PHE A 401 -1.577 3.105 -19.793 1.00 3.36 O ANISOU 35 O PHE A 401 532 379 367 31 -39 96 O ATOM 36 CB PHE A 401 -0.418 0.612 -18.605 1.00 2.39 C ANISOU 36 CB PHE A 401 356 285 268 29 -19 59 C ATOM 37 CG PHE A 401 -0.136 -0.251 -17.393 1.00 1.48 C ANISOU 37 CG PHE A 401 218 172 173 33 -20 47 C ATOM 38 CD1 PHE A 401 -0.893 -0.136 -16.232 1.00 1.35 C ANISOU 38 CD1 PHE A 401 192 150 172 37 -29 51 C ATOM 39 CD2 PHE A 401 0.888 -1.188 -17.419 1.00 3.59 C ANISOU 39 CD2 PHE A 401 476 446 444 35 -13 30 C ATOM 40 CE1 PHE A 401 -0.614 -0.920 -15.112 1.00 2.37 C ANISOU 40 CE1 PHE A 401 311 278 312 38 -31 44 C ATOM 41 CE2 PHE A 401 1.165 -1.977 -16.308 1.00 4.15 C ANISOU 41 CE2 PHE A 401 534 512 530 41 -22 23 C ATOM 42 CZ PHE A 401 0.416 -1.846 -15.156 1.00 3.96 C ANISOU 42 CZ PHE A 401 510 481 514 41 -31 33 C ATOM 43 N GLY A 402 0.553 3.358 -20.489 1.00 4.01 N ANISOU 43 N GLY A 402 625 471 425 -5 11 95 N ATOM 44 CA GLY A 402 0.184 4.109 -21.681 1.00 5.61 C ANISOU 44 CA GLY A 402 874 662 594 -11 5 118 C ATOM 45 C GLY A 402 -0.228 3.225 -22.846 1.00 7.18 C ANISOU 45 C GLY A 402 1088 877 762 -4 -5 113 C ATOM 46 O GLY A 402 0.070 2.026 -22.860 1.00 7.43 O ANISOU 46 O GLY A 402 1099 929 796 0 2 91 O ATOM 47 OXT GLY A 402 -0.868 3.679 -23.810 1.00 7.33 O ANISOU 47 OXT GLY A 402 1129 892 766 1 -23 122 O TER 48 GLY A 402 ATOM 49 N GLY B 396 -1.180 -8.465 -24.596 1.00 3.06 N ANISOU 49 N GLY B 396 491 386 285 74 -96 -105 N ATOM 50 CA GLY B 396 -0.276 -8.781 -23.503 1.00 3.34 C ANISOU 50 CA GLY B 396 506 410 351 80 -84 -107 C ATOM 51 C GLY B 396 -0.944 -8.687 -22.144 1.00 2.66 C ANISOU 51 C GLY B 396 409 305 296 72 -98 -80 C ATOM 52 O GLY B 396 -2.166 -8.709 -22.040 1.00 3.46 O ANISOU 52 O GLY B 396 513 399 403 61 -116 -68 O ATOM 53 N PHE B 397 -0.122 -8.580 -21.103 1.00 2.34 N ANISOU 53 N PHE B 397 356 259 274 77 -87 -74 N ATOM 54 CA PHE B 397 -0.568 -8.490 -19.720 1.00 2.13 C ANISOU 54 CA PHE B 397 324 217 270 68 -95 -50 C ATOM 55 C PHE B 397 -0.072 -7.170 -19.148 1.00 3.57 C ANISOU 55 C PHE B 397 493 414 448 66 -75 -33 C ATOM 56 O PHE B 397 1.133 -6.893 -19.185 1.00 3.19 O ANISOU 56 O PHE B 397 435 377 400 74 -60 -45 O ATOM 57 CB PHE B 397 0.017 -9.652 -18.895 1.00 3.10 C ANISOU 57 CB PHE B 397 450 313 415 79 -110 -59 C ATOM 58 CG PHE B 397 -0.375 -9.624 -17.436 1.00 2.60 C ANISOU 58 CG PHE B 397 390 233 364 68 -116 -33 C ATOM 59 CD1 PHE B 397 0.298 -8.820 -16.535 1.00 3.97 C ANISOU 59 CD1 PHE B 397 554 416 539 72 -107 -21 C ATOM 60 CD2 PHE B 397 -1.437 -10.388 -16.978 1.00 2.62 C ANISOU 60 CD2 PHE B 397 408 213 376 49 -130 -21 C ATOM 61 CE1 PHE B 397 -0.069 -8.789 -15.194 1.00 2.47 C ANISOU 61 CE1 PHE B 397 372 213 352 61 -111 1 C ATOM 62 CE2 PHE B 397 -1.803 -10.365 -15.642 1.00 4.13 C ANISOU 62 CE2 PHE B 397 606 392 570 34 -130 3 C ATOM 63 CZ PHE B 397 -1.127 -9.560 -14.753 1.00 3.90 C ANISOU 63 CZ PHE B 397 571 374 537 41 -120 14 C ATOM 64 N ASN B 398 -0.998 -6.361 -18.626 1.00 1.78 N ANISOU 64 N ASN B 398 264 189 222 54 -75 -10 N ATOM 65 CA ASN B 398 -0.682 -5.168 -17.841 1.00 1.61 C ANISOU 65 CA ASN B 398 235 176 203 51 -61 5 C ATOM 66 C ASN B 398 -1.294 -5.354 -16.460 1.00 2.39 C ANISOU 66 C ASN B 398 330 262 315 44 -68 19 C ATOM 67 O ASN B 398 -2.512 -5.514 -16.339 1.00 2.32 O ANISOU 67 O ASN B 398 321 251 311 33 -75 25 O ATOM 68 CB ASN B 398 -1.279 -3.911 -18.477 1.00 2.04 C ANISOU 68 CB ASN B 398 292 240 242 46 -56 18 C ATOM 69 CG ASN B 398 -0.631 -3.554 -19.788 1.00 5.17 C ANISOU 69 CG ASN B 398 701 649 615 46 -44 11 C ATOM 70 OD1 ASN B 398 0.573 -3.743 -19.979 1.00 4.54 O ANISOU 70 OD1 ASN B 398 616 577 532 48 -27 -3 O ATOM 71 ND2 ASN B 398 -1.433 -3.033 -20.714 1.00 4.75 N ANISOU 71 ND2 ASN B 398 664 598 542 45 -53 19 N ATOM 72 N GLY B 399 -0.464 -5.341 -15.427 1.00 2.00 N ANISOU 72 N GLY B 399 279 209 273 48 -66 20 N ATOM 73 CA GLY B 399 -0.978 -5.512 -14.088 1.00 1.58 C ANISOU 73 CA GLY B 399 231 146 223 39 -70 34 C ATOM 74 C GLY B 399 -0.304 -4.606 -13.086 1.00 1.50 C ANISOU 74 C GLY B 399 216 143 212 42 -64 38 C ATOM 75 O GLY B 399 0.929 -4.518 -13.064 1.00 2.80 O ANISOU 75 O GLY B 399 374 309 381 54 -66 27 O ATOM 76 N GLY B 400 -1.102 -3.924 -12.266 1.00 1.33 N ANISOU 76 N GLY B 400 193 126 187 31 -55 48 N ATOM 77 CA GLY B 400 -0.573 -3.108 -11.192 1.00 1.64 C ANISOU 77 CA GLY B 400 231 170 223 33 -51 49 C ATOM 78 C GLY B 400 -1.127 -3.568 -9.864 1.00 1.82 C ANISOU 78 C GLY B 400 269 187 233 22 -52 59 C ATOM 79 O GLY B 400 -2.340 -3.757 -9.731 1.00 3.26 O ANISOU 79 O GLY B 400 452 373 414 7 -41 64 O ATOM 80 N PHE B 401 -0.253 -3.766 -8.877 1.00 1.52 N ANISOU 80 N PHE B 401 246 144 187 28 -65 59 N ATOM 81 CA PHE B 401 -0.623 -4.410 -7.623 1.00 3.07 C ANISOU 81 CA PHE B 401 471 333 364 16 -69 73 C ATOM 82 C PHE B 401 -0.128 -3.557 -6.463 1.00 2.70 C ANISOU 82 C PHE B 401 430 295 302 20 -70 69 C ATOM 83 O PHE B 401 1.065 -3.240 -6.389 1.00 3.12 O ANISOU 83 O PHE B 401 476 348 361 38 -89 57 O ATOM 84 CB PHE B 401 0.000 -5.811 -7.548 1.00 3.10 C ANISOU 84 CB PHE B 401 491 319 369 22 -87 72 C ATOM 85 CG PHE B 401 -0.367 -6.700 -8.708 1.00 3.28 C ANISOU 85 CG PHE B 401 509 332 406 20 -88 70 C ATOM 86 CD1 PHE B 401 0.308 -6.616 -9.923 1.00 2.31 C ANISOU 86 CD1 PHE B 401 365 212 300 36 -92 53 C ATOM 87 CD2 PHE B 401 -1.398 -7.618 -8.582 1.00 2.94 C ANISOU 87 CD2 PHE B 401 484 274 358 -2 -85 83 C ATOM 88 CE1 PHE B 401 -0.043 -7.439 -10.993 1.00 3.35 C ANISOU 88 CE1 PHE B 401 498 334 441 36 -96 48 C ATOM 89 CE2 PHE B 401 -1.753 -8.443 -9.651 1.00 3.92 C ANISOU 89 CE2 PHE B 401 607 386 497 -5 -91 78 C ATOM 90 CZ PHE B 401 -1.074 -8.351 -10.851 1.00 3.43 C ANISOU 90 CZ PHE B 401 526 327 449 17 -99 60 C ATOM 91 N GLY B 402 -1.035 -3.192 -5.558 1.00 2.15 N ANISOU 91 N GLY B 402 370 236 212 3 -50 73 N ATOM 92 CA GLY B 402 -0.667 -2.457 -4.360 1.00 3.70 C ANISOU 92 CA GLY B 402 577 442 387 5 -52 67 C ATOM 93 C GLY B 402 0.313 -3.200 -3.466 1.00 7.12 C ANISOU 93 C GLY B 402 1046 861 798 14 -85 75 C ATOM 94 O GLY B 402 0.347 -4.438 -3.475 1.00 7.89 O ANISOU 94 O GLY B 402 1156 943 898 10 -93 84 O ATOM 95 OXT GLY B 402 1.087 -2.585 -2.711 1.00 6.97 O ANISOU 95 OXT GLY B 402 1032 848 769 25 -101 63 O TER 96 GLY B 402 HETATM 97 O HOH A 501 -1.927 8.017 -3.768 1.00 5.44 O ANISOU 97 O HOH A 501 702 661 706 60 1 -85 O HETATM 98 O HOH A 502 0.294 4.099 -26.286 1.00 11.35 O ANISOU 98 O HOH A 502 1698 1418 1198 -37 16 134 O HETATM 99 O HOH A 503 -0.928 -0.394 0.648 1.00 9.90 O ANISOU 99 O HOH A 503 1444 1277 1040 -16 -30 36 O HETATM 100 O HOH B 501 2.587 -2.907 -0.541 1.00 8.11 O ANISOU 100 O HOH B 501 1214 988 880 39 -146 54 O HETATM 101 O HOH B 502 0.772 -6.014 -1.288 1.00 6.37 O ANISOU 101 O HOH B 502 1031 728 660 1 -119 102 O HETATM 102 O HOH B 503 -1.869 -5.857 -4.277 1.00 8.07 O ANISOU 102 O HOH B 503 1187 956 925 -34 -54 108 O HETATM 103 O HOH B 504 -2.422 -11.022 -24.672 1.00 4.69 O ANISOU 103 O HOH B 504 705 547 529 75 -153 -145 O HETATM 104 O HOH B 505 3.145 -5.510 0.125 1.00 7.26 O ANISOU 104 O HOH B 505 1155 838 764 43 -181 78 O MASTER 203 0 0 0 0 0 0 6 102 2 0 2 END